Non-alcoholic fatty liver disease: Definition and subtypes

被引：123

作者：

Han, Seul Ki ^{[1
,2
,3
]}

Baik, Soon Koo ^{[1
,2
,3
]}

Kim, Moon Young ^{[1
,2
,3
]}

机构：

[1] Yonsei Univ, Dept Internal Med, Wonju Coll Med, Wonju, South Korea

[2] Yonsei Univ, Regenerat Med Res Ctr, Wonju Coll Med, Wonju, South Korea

[3] Yonsei Univ, Cell Therapy & Tissue Engn Ctr, Wonju Coll Med, Wonju, South Korea

来源：

CLINICAL AND MOLECULAR HEPATOLOGY | 2023年 / 29卷

关键词：

Non-alcoholic fatty liver disease; Steatohepatitis; Fibrosis; METABOLICALLY HEALTHY OBESITY; CRYPTOGENIC CIRRHOSIS; RISK-FACTORS; FIBROSIS PROGRESSION; NATURAL-HISTORY; HEPATOCELLULAR-CARCINOMA; HISTOLOGIC FEATURES; STEATOHEPATITIS; ASSOCIATION; PREVALENCE;

D O I：

10.3350/cmh.2022.0424

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide, with a global prevalence of approximately 30%. However, the prevalence of NAFLD has been variously reported depending on the comorbidities. The rising prevalence of obesity in both the adult and pediatric populations is projected to consequently continue increasing NAFLD prevalence. It is a major cause of chronic liver disease worldwide, including cirrhosis and hepatocellular carcinoma (HCC). NAFLD has a variety of clinical phenotypes and heterogeneity due to the complexity of pathogenesis and clinical conditions of its occurrence, resulting in various clinical prognoses. In this article, we briefly described the basic definition of NAFLD and classified the subtypes based on current knowledge in this field.

引用

页码：S5 / S16

页数：12

共 91 条

[1] A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease [J].

Abul-Husn, N. S. ;

Cheng, X. ;

Li, A. H. ;

Xin, Y. ;

Schurmann, C. ;

Stevis, P. ;

Liu, Y. ;

Kozlitina, J. ;

Stender, S. ;

Wood, G. C. ;

Stepanchick, A. N. ;

Still, M. D. ;

McCarthy, S. ;

O'Dushlaine, C. ;

Packer, J. S. ;

Balasubramanian, S. ;

Gosalia, N. ;

Esopi, D. ;

Kim, S. Y. ;

Mukherjee, S. ;

Lopez, A. E. ;

Fuller, E. D. ;

Penn, J. ;

Chu, X. ;

Luo, J. Z. ;

Mirshahi, U. L. ;

Carey, D. J. ;

Still, C. D. ;

Feldman, M. D. ;

Small, A. ;

Damrauer, S. M. ;

Rader, D. J. ;

Zambrowicz, B. ;

Olson, W. ;

Murphy, A. J. ;

Borecki, I. B. ;

Shuldiner, A. R. ;

Reid, J. G. ;

Overton, J. D. ;

Yancopoulos, G. D. ;

Hobbs, H. H. ;

Cohen, J. C. ;

Gottesman, O. ;

Teslovich, T. M. ;

Baras, A. ;

Mirshahi, T. ;

Gromada, J. ;

Dewey, F. E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (12) :1096-1106

[2] Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease [J].

Angulo, Paul ;

Kleiner, David E. ;

Dam-Larsen, Sanne ;

Adams, Leon A. ;

Bjornsson, Einar S. ;

Charatcharoenwitthaya, Phunchai ;

Mills, Peter R. ;

Keach, Jill C. ;

Lafferty, Heather D. ;

Stahler, Alisha ;

Haflidadottir, Svanhildur ;

Bendtsen, Flemming .

GASTROENTEROLOGY, 2015, 149 (02) :389-+

[3]

[Anonymous], 2020, LANCET GASTROENTEROL, V5, P419, DOI [10.1053/j.gastro.2019.11.312, 10.1016/S2468-1253(20)30091-1]

[4] Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis [J].

Argo, Curtis K. ;

Northup, Patrick G. ;

Al-Osaimi, Abdullah M. S. ;

Caldwell, Stephen H. .

JOURNAL OF HEPATOLOGY, 2009, 51 (02) :371-379

[5] TM6SF2 and MBOAT7 Gene Variants in Liver Fibrosis and Cirrhosis [J].

Basyte-Bacevice, Viktorija ;

Skieceviciene, Jurgita ;

Valantiene, Irena ;

Sumskiene, Jolanta ;

Petrenkiene, Vitalija ;

Kondrackiene, Jurate ;

Petrauskas, Dalius ;

Lammert, Frank ;

Kupcinskas, Juozas .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (06)

[6] The Natural History of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis or Cirrhosis: An International Collaborative Study [J].

Bhala, Neeraj ;

Angulo, Paul ;

van der Poorten, David ;

Lee, Eric ;

Hui, Jason M. ;

Saracco, Giorgio ;

Adams, Leon A. ;

Charatcharoenwitthaya, Phunchai ;

Topping, Joanne H. ;

Bugianesi, Elisabetta ;

Day, Christopher P. ;

George, Jacob .

HEPATOLOGY, 2011, 54 (04) :1208-1216

[7]

Bondini Silvia, 2007, Clin Liver Dis, V11, P17

[8] The impact of metabolic health on non-alcoholic fatty liver disease (NAFLD). A single center experience [J].

Boulouta, Anna ;

Aggeletopoulou, Ioanna ;

Kanaloupitis, Stavros ;

Tsounis, Efthymios P. ;

Issaris, Vasileios ;

Papantoniou, Konstantinos ;

Apostolos, Anastasios ;

Tsaplaris, Paraskevas ;

Pastras, Ploutarchos ;

Sotiropoulos, Christos ;

Tsintoni, Aggeliki ;

Diamantopoulou, Georgia ;

Thomopoulos, Konstantinos ;

Michalaki, Marina ;

Triantos, Christos .

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (05)

[9] Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings [J].

Brunt, Elizabeth M. ;

Kleiner, David E. ;

Wilson, Laura A. ;

Belt, Patricia ;

Neuschwander-Tetri, Brent A. .

HEPATOLOGY, 2011, 53 (03) :810-820

[10] Histopathology of nonalcoholic fatty liver disease [J].

Brunt, Elizabeth M. ;

Tiniakos, Dina G. .

WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (42) :5286-5296

← 1 2 3 4 5 6 7 8 9 10 →